drug trial
AbbVie, Janssen’s Imbruvica gets European approval to teat CLL
May 31, 2016Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, CLL, drug trial, regulation
AbbVie (NYSE: ABBV) on Tuesday said Imbruvica (ibrutinib) has secured European regulatory backing to treat chronic lymphocytic leukemia or CLL. …
EU green-lights Samsung Bioepis, Biogen’s Remicade biosimilar Flixabi
May 31, 2016Manufacturing and Production, Research and Development, Sales and Marketing Biogen, Samsung Bioepis, biosimilar, drug trial, regulation, research
Samsung Bioepis and partner Biogen (Nasdaq: BIIB) said the European Commission has approved Flixabi, a biosimilar version of Johnson & …
Roche says comparison study for its Gazyva/ Gazyvaro showed superior progression-free survival in follicular lymphoma
May 27, 2016Medical Communications, Research and Development Comparison Study, Roche, drug trial, follicular lymphoma
Roche (SIX: ROG) on Friday said late-stage comparison trials for its drug to treat a slower form of non-Hodgkin lymphoma …
AstraZeneca says its Faslodex shows superiority in comparison study for advanced breast cancer
May 27, 2016Medical Communications, Research and Development, Sales and Marketing AstraZeneca, breast cancer, comparision study, drug trial
UK drugmaker AstraZeneca (LSE: AZN) on Friday said late-stage comparison trials for its drug to treat advanced breast cancer showed …
Janssen says its Stelara maintained clinical remission in Crohn’s disease in Phase III trials
May 26, 2016Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelara, crohn's disease, drug trial
Janssen said its maintenance therapy for Crohn’s disease showed remission for patients in late-stage trials. The company said a significant …
GSK says asthma drug Breo shows superior results over standard care in major study
May 24, 2016Research and Development, Sales and Marketing COPD, GSK, asthma, breo, drug trial
UK drugmaker GlaxoSmithKline (LSE: GSK) on Tuesday said inhaled medicine Breo proved significantly better than standard care in a major …
Pfizer says EMA lifts warning on its smoking cessation drug Champix
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing Champix, EMA, Pfizer, anti-smoking, drug trial
US pharma giant Pfizer (NYSE: PFE) said the European Medicines Agency has lifted a warning on its anti-smoking drug Champix …
US FDA advisors question usefulness of Sanofi’s combination diabetes therapy
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, US FDA, diabetes, drug trial, regulation
US Food and Drug Administration staff questioned the benefits of French drugmaker Sanofi’s (Euronext: SAN) diabetes drug candidate as well …
BMS says Phase III trials for Opdivo show improved overall survival in lung cancer
May 19, 2016Research and Development Bristol-Myers Squibb, drug trial, lung cancer, opdivo
Bristol-Myers Squibb (NYSE:BMY) said late-stage trials for its immuno-therapy Opdivo (nivolumab) showed improved overall survival in lung cancer at the …
AstraZeneca says its respiratory biologic meets primary endpoint in Phase III trial
May 17, 2016Manufacturing and Production, Research and Development AstraZeneca, asthma drug, benralizumab, drug trial
UK-based AstraZeneca (LSE: AZN) on Tuesday said late stage trials for its biologic asthma drug met the primary endpoint. Chief …
Aduro’s pancreatic cancer immunotherapy fails Phase II trials; shares plunge
May 17, 2016Manufacturing and Production, Research and Development, Sales and Marketing Aduro Biotech, Pancreatic cancer, Stock, drug trial, markets
Shares in Aduro Biotech (Nasdaq: ADRO) dropped to closed down over 16% after the company said mid-stage trials of its …
Novartis says trials show its COPD drug more effective versus GSK’s Seretide
May 16, 2016Research and Development, Sales and Marketing GSK, Novartis, drug trial, research
Swiss drug firm Novartis (VTX: NOVN) said its asthma drug showed efficacy over GlaxoSmithKline’s (LSE: GSK) medicine in a comparison …
AstraZeneca says its trial drug for thyroid cancer granted US FDA orphan drug designation
May 12, 2016Research and Development, Sales and Marketing AstraZeneca, Orphan Drug Designation, US FDA, drug trial, regulation
AstraZeneca (LSE: AZN) on Thursday said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation its trial …
Santen Pharmaceutical says eye allergy drug meets primary endpoints in Phase III trials
May 11, 2016Research and Development, Sales and Marketing Eye Allergy, Santen Pharmaceutical, drug trial, phase III
Santen Pharmaceutical said late stage trials for its drug to treat an allergic eye condition in children met its primary …
Regeneron says trial drug for osteoarthritis pain meets primary endpoint in Phase II trials
May 3, 2016Manufacturing and Production, Research and Development Phase II, Regeneron Pharmaceuticals, drug trial, osteoarthritis, phase III
Regeneron Pharmaceuticals (Nasdaq: REGN) said mid-stage trials for its drug candidate to treat osteoarthritis pain med its primary endpoint. The …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
